Stage II Bladder Urothelial Carcinoma AJCC v6 and v7
5 clinical trials · Condition
◉ Watch Stage II Bladder Urothelial Carcinoma AJCC v6 and v7
| Record | Firm | Date |
|---|---|---|
| Radiation Therapy and Pembrolizumab in Treating Patients With Localized Urothelial Bladder Cancer (NCT03419130) | University of California, San Francisco | 2018-07-18 |
| Nivolumab and RT in Treating Patients With Localized/Locally Advanced Urothelial Bladder Cancer Ineligible for Chemo (NCT03421652) | Barbara Ann Karmanos Cancer Institute | 2018-04-24 |
| Testing MK-3475 (Pembrolizumab) After Surgery for Localized Muscle-Invasive Bladder Cancer and Locally Advanced Urothelial Cancer (NCT03244384) | National Cancer Institute (NCI) | 2017-11-03 |
| Durvalumab and Tremelimumab in Treating Patients With Muscle-Invasive, High-Risk Urothelial Cancer That Cannot Be Treated With Cisplatin-Based Therapy Before Surgery (NCT02812420) | M.D. Anderson Cancer Center | 2017-03-07 |
Track Stage II Bladder Urothelial Carcinoma AJCC v6 and v7 automatically
Every clearance here is in the API, with alerts when new ones post.